SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):302P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kim, D.
Right arrow Articles by Kim, B.
PubMed
Right arrow Articles by Kim, D.
Right arrow Articles by Kim, B.

Radiopharmaceutical Chemistry: New Chemistry-Other

New Chemistry-Other Posters

Synthesis of F-18 labeled 6-thia fatty acid analog and its evaluation in mouse heart

D. Kim1, Y. Choe1, J. Choi1, Y. Choi1, K. Lee1 and B. Kim1

1 Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

1285

Objectives: Fatty acids are substrates for energy metabolism in myocardium. Therefore, radiolabeled fatty acid analogs are useful for evaluation of fatty acid utilization in myocardium. In the present study, 17-[4-(2-[F-18]fluoroethyl)-1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic acid ([F-18]1) was synthesized and its utility was evaluated in mouse heart.

Methods: [F-18]1 was synthesized from 4-[F-18]fluoro-1-butyne and 17-azido 6-thia fatty acid analog using a click labeling method. ICR mice injected with [F-18]1 were sacrificed at 1, 5, 10, 30, and 60 min p.i., and the tissues were counted. In another set of experiment, ICR mice were injected i.p. with etomoxir (40 mg/kg) at 2 h prior to the injection with [F-18]1 and sacrificed at 10 and 30 min after injection of the radiotracer. In metabolite analysis experiment, the heart samples were collected at 10 and 30 min p.i., homogenized in a mixture of CHCl3-CH3OH-NaOH, and centrifuged. The resulting organic layer, aqueous layer, and the pellet were respectively counted and analyzed.

Results: Tissue distribution of [F-18]1 in mice showed high radioactivity accumulation in the heart (3.70 %ID/g at 1 min, 3.28 %ID/g at 10 min, and 3.01 %ID/g at 60 min). The maximal heart to blood uptake ratio was 6.5 at 5 min, and myocardial elimination half-life was longer than 60 min. Pretreatment of etomoxir, a CPT I inhibitor, reduced the myocardial uptake at 30 min by 53%. In metabolite analysis, most radioactivity was detected in the pellet (74%) when the heart samples were homogenized. These results, along with precipitation upon TCA treatment of the pellet suggest metabolic trapping of [F-18]1 in myocardium.

Conclusions: [F-18]1 may hold promise as a PET radiotracer for evaluation of fatty acid utilization in myocardium.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kim, D.
Right arrow Articles by Kim, B.
PubMed
Right arrow Articles by Kim, D.
Right arrow Articles by Kim, B.